- Volume 15 Issue 23
DOI QR Code
Association between a p73 Gene Polymorphism and Genetic Susceptibility to Non-small Cell Lung Cancer in the South of China
- Wang, Shuang-Shuang (Key Laboratory of Green Packaging and Application of Biological Nanotechnology, Hunan University of Technology) ;
- Guo, Hai-Yan (Department of Obstetrics and Gynecology, Xi'an No.4 Hospital) ;
- Dong, Lin-Li (Key Laboratory of Green Packaging and Application of Biological Nanotechnology, Hunan University of Technology) ;
- Zhu, Xiang-Qian (Hunan Provincial Tumor Hospital) ;
- Ma, Liang (Key Laboratory of Green Packaging and Application of Biological Nanotechnology, Hunan University of Technology) ;
- Li, Wen (Key Laboratory of Green Packaging and Application of Biological Nanotechnology, Hunan University of Technology) ;
- Tang, Jian-Xin (Key Laboratory of Green Packaging and Application of Biological Nanotechnology, Hunan University of Technology)
- Published : 2015.01.06
Background: This study aimed to identify any association between the p73 gene G4C14-to-A4T14 polymorphism and risk of non-small cell lung cancer (NSCLC) in the south of China. Materials and Methods: We genotyped the p73 gene polymorphism of peripheral blood DNA from 168 patients with NSCLC and 195 normal controls using HRM (high resolution melting) and PCR-CTPP (polymerase chain reaction with confronting two-pair primers). Results: The results of genotyping by HRM and PCR-CTPP were consistent with direct sequencing, the p73 genotype distribution in 168 lung cancer patients being as follows: GC/GC 101 cases (60.1%), GC/AT 59 cases (35.1%), AT/AT 8 cases (4.8%). The carriers of AT/AT genotype had a significantly reduced risk of NSCLC (OR=0.370; 95%CI: 0.170-0.806; p=0.010) as compared with non-carriers. However, we found no relations between p73 genotypes and histological type (p=0.798,
NSCLC;p73 gene polymorphism;HRM and PCR-CTPP
Supported by : National Natural Science Foundation of China
- Choi JE, Kang HG, Chae MH, et al (2006). No association between p73 G4C14-TOA4T14 polymorphism and the risk of lung cancer in a Korean population. Biochem Genet, 44, 533-40. https://doi.org/10.1007/s10528-006-9056-8
- Cheng Z, Wang W, Song YN, et al (2012). HoGG1, p53 genes, and smoking interactions are associated with the development of lung cancer. Asian Pac J Cancer Prev, 13, 1803-8. https://doi.org/10.7314/APJCP.2012.13.5.1803
- Erali M, Voelkerding KV, Wittwer CT, et al (2008). High resolution melting applications for clinical laboratory medicine. Exp Mol Pathol, 85, 50-8. https://doi.org/10.1016/j.yexmp.2008.03.012
- Hu ZB, Ma HX, Tan W et al (2005). The research between genetic susceptibility to lung cancer and p73 gene polymorphism. Chin J epidemiol, 26,106-9.
- Huang XE, Hamajima N, Katsuda N, et al (2003). Association of p53 codon arg72pro and p73 G4C14-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer. Breast cancer, 10, 307-11. https://doi.org/10.1007/BF02967650
- Hu Z, Miao X, Ma H, et al (2005). Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population. Int J Cancer, 114, 455-60. https://doi.org/10.1002/ijc.20746
- Hiraki A, Matsuo K, Hamajima N, et al (2003). Different risk relations with smoking for non-small cell lung cancer: comparison of TP53 and TP73 genotypes. Asian Pacific J Cancer Prev, 4, 107-12.
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA: A Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Kaghad M, Bonnet H, Yang A, et al (1997). Monoallelically expressed gene related to p53 at lp36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90, 809-19. https://doi.org/10.1016/S0092-8674(00)80540-1
- Kramer A, Thunnissen A, Gallegos R, et al (2009). A fast, sensitive and accurate high resolution melting (HRM) technology-based assay to screen for common K-ras mutations. Cell Oncol, 31,161-7.
- Liu KS, Zhan MY, Zheng PE (2008). Loss of p73 expression in six non-small cell lung cancer cell lines is associated with 5'CpG island methylation. Exp Mol Pathol, 84, 59-63. https://doi.org/10.1016/j.yexmp.2007.10.002
- Lo Iacono M, Monica V, Saviozzi S et al (2011). p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue. J Thoracic Oncol, 6, 473-81. https://doi.org/10.1097/JTO.0b013e31820b86b0
- Li Q, Athan ES, Wei M, et al (2004). Tp73 allelic expression in human brain and allele frequencies in Alzheimer's disease. BMC Med Genet, 5, 5-14.
- Lee KE, Hong YS, Kim BG, et al (2010). p73 G4C14 to A4T14 polymorphism is associated with colorectal cancer risk and survival. World J Gastroenterology, 16, 4448-54. https://doi.org/10.3748/wjg.v16.i35.4448
- Li GJ, Sturgis EM, Wang LE, et al (2004). Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis, 25, 1911-6. https://doi.org/10.1093/carcin/bgh197
- Li M, Zhang QP, Liu LN, et al (2011). The difference clinical significance of EGFR mutations in exon 19 and 21 in nonsmall cell lung cancer. Neoplasma, 58, 74-81. https://doi.org/10.4149/neo_2011_01_74
- Li G, Wang LE, Chamberlain RM, et al (2004). p73 G4C14-A4T14 polymorphism and risk of lung cancer. Cancer Res, 64, 6863-6. https://doi.org/10.1158/0008-5472.CAN-04-1804
- Melino G., Laurenzi VD and Vousden KH (2002). p73: friend or foe in tumorigenesis. Nat Rev Cancer, 2, 605-15. https://doi.org/10.1038/nrc861
- Maria E, Karl VV, Carl TW, et al (2008). High resolution melting applications for clinical laboratory medicine. Exp Mol Pathol, 85, 50-8. https://doi.org/10.1016/j.yexmp.2008.03.012
- Michael K, Genni M N, David M T, et al (2006). High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS coden and 13 mutations in non-small cell lung cancer. BMC Cancer, 6, 295. https://doi.org/10.1186/1471-2407-6-295
- Niwa Y, Hamajima N, Atsuta Y, et al (2004). Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese. Cancer Lett, 205, 55-60. https://doi.org/10.1016/j.canlet.2003.11.014
- Peters MA, Janer M, Kolb S, et al (2001). Germline mutations in the p73 gene do not predispose to familial prostate-brain cancer. The Prostate, 48, 292-6. https://doi.org/10.1002/pros.1109
- Pfeifer D, Arbman G, Sun XF (2005). Polymorphism of the p73 gene in relation to colorectal cancer risk and survival. Carcinogenesis, 26, 103-7.
- Ryan BM, Mcmanus R, Daly JS, et al (2001). A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma. Br J Cancer, 85, 1499-1503. https://doi.org/10.1054/bjoc.2001.2066
- Uramoto H, Sugio K, Oyama T et al (2006). Expression of the p53 family in lung cancer. Anticancer Res, 26, 1785-90.
- Yang SD, Cai YL, Jiang P et al (2014). Association of a miR-502-binding site single nucleotide polymorphism in the 3'-untranslated region of SET8 and the TP53 codon 72 polymorphism with cervical cancer in the Chinese population. Asian Pac J Cancer Prev, 15, 6505-10. https://doi.org/10.7314/APJCP.2014.15.16.6505
- Zhu J, Jiang J, Zhou W, et al (1998). The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res, 58, 5061-5.
- Zhang XA, Li X, Wu ZH, et al (2013). The p73 G4C14-TOA4T14 polymorphism is associated with risk of lung cancer in the Han Nationality of North China. Mol Carcinogenesis, 52, 387-91. https://doi.org/10.1002/mc.21869
- Zhou BB, Elledge SJ (2000). The DNA damage response: putting checkouts in perspective. Nature, 408, 433-9. https://doi.org/10.1038/35044005
- Association between the p73 gene G4C14-to-A4T14 single nucleotide polymorphism and risk of cervical cancer by high resolution melting and PCR with confronting two-pair primers in a Chinese population vol.12, pp.1, 2016, https://doi.org/10.3892/ol.2016.4655
- Association of p73 gene G4C14-A4T14 polymorphism and MDM2 gene SNP309 with non-small cell lung cancer risk in a Chinese population vol.14, pp.2, 2017, https://doi.org/10.3892/ol.2017.6327